← All trials
NCT07166081
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Aug 11, 2025
- Primary completion
- Jan 12, 2026
- Completion date
- May 13, 2026
- First posted
- Sep 10, 2025
- Last posted
- Sep 19, 2025
- Enrollment
- 80
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Government of ChinaLead sponsor
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.